O'Connor Daniel J. 4
4 · Ambrx Biopharma Inc. · Filed Apr 28, 2023
Insider Transaction Report
Form 4
O'Connor Daniel
DirectorPresident and CEO
Transactions
- Award
Ordinary Shares
2023-04-26+2,750,000→ 2,750,000 total
Footnotes (2)
- [F1]The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents seven Ordinary Shares of the Issuer.
- [F2]Represents grant of Restricted Stock Units (the "RSUs") payable solely in Ordinary Shares of the Issuer that vest as follows: (i) 25% of the RSUs will vest on the six-month anniversary of the grant date of April 26, 2023 (the "Grant Date"), (ii) 25% of the RSUs will vest on the 12-month anniversary of the Grant Date, (iii) 25% of the RSUs will vest on the 24-month anniversary of the Grant Date, and (iv) 25% of the RSUs will vest on the 36-month anniversary of the Grant Date.